In an emergency dilation and curettage (D&C) for a missed miscarriage with significant per vaginal (PV) bleeding, is a Bakri balloon suitable?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bakri Balloon for Emergency D&C with Significant Bleeding in Missed Miscarriage

Yes, a Bakri balloon is suitable and should be considered for managing significant hemorrhage during or after emergency D&C for missed miscarriage when medical management (uterotonics) fails to control bleeding.

Primary Management Algorithm

The approach to significant bleeding during emergency D&C for missed miscarriage follows this hierarchy:

  1. Complete the evacuation expeditiously - Retained tissue is often the primary cause of ongoing hemorrhage
  2. Administer uterotonics (oxytocin, methylergonovine, misoprostol) for uterine atony
  3. If bleeding persists despite medical management → Bakri balloon tamponade
  4. If balloon fails → Consider uterine artery embolization or surgical intervention

Evidence Supporting Bakri Balloon Use

While the provided guidelines primarily address gestational trophoblastic disease and postpartum hemorrhage, the RCOG Green-Top Guideline explicitly states: "Consideration should be given to balloon tamponade...to reduce the risk of hysterectomy for women who wish to preserve fertility" in the context of persistent heavy vaginal bleeding with retained pregnancy tissue 1.

Success Rates and Safety Profile

Research demonstrates that Bakri balloon tamponade achieves:

  • Overall success rate of 93.6% (102/109 cases) in controlling postpartum hemorrhage 2
  • Successful hemostasis in 95% of cases when placed vaginally 2
  • Only 1% hysterectomy rate among women requiring balloon placement 3
  • No intrauterine infections reported in multicenter analysis 2

The balloon has been successfully used specifically for second-trimester postabortion hemorrhage unresponsive to medical therapy 4, and even for delayed hemorrhage up to one month postpartum 5.

Practical Implementation

When to Deploy the Bakri Balloon

Use the balloon when:

  • Estimated blood loss exceeds 500-1000 mL during or immediately after D&C
  • Bleeding continues despite complete evacuation (confirmed by ultrasound if possible)
  • Uterotonics have been administered without adequate response
  • Patient shows signs of hemodynamic instability

Placement Technique

  • Can be placed vaginally after D&C (preferred route, 95% success rate) 2
  • Fill with 300-500 mL sterile saline (adjust based on uterine size and bleeding control)
  • Optimal retention time: approximately 22 hours for successful hemostasis 2
  • Monitor for balloon displacement (occurs in approximately 9% of cases) 3

Critical Caveats

Distinguish from Molar Pregnancy

The guidelines emphasize a crucial distinction: If gestational trophoblastic disease (molar pregnancy) is suspected or confirmed, avoid routine oxytocic use prior to complete evacuation due to theoretical risk of trophoblastic tissue embolization 1. However, in life-threatening hemorrhage, this risk must be weighed against immediate mortality risk 1.

For standard missed miscarriage (non-molar): This concern does not apply, and uterotonics should be used liberally.

Predictors of Balloon Failure

Factors associated with Bakri balloon failure include 2:

  • Coagulopathy at time of insertion
  • Thrombocytopenia
  • Blood loss >500 mL within first hour of placement
  • Failure to achieve complete uterine evacuation

Concurrent Resuscitation

While managing hemorrhage with the balloon:

  • Initiate massive transfusion protocol if blood loss exceeds 1500 mL
  • Maintain platelet count >50,000/mm³
  • Consider tranexamic acid (1g IV) for suspected hyperfibrinolysis 6
  • Ensure adequate IV access and hemodynamic monitoring

Alternative and Adjunctive Measures

If Bakri balloon is unavailable or fails:

  • Uterine packing with gauze (less effective, more difficult to remove)
  • Uterine artery embolization (requires interventional radiology availability) 1, 7
  • Surgical options: B-Lynch suture, uterine artery ligation (rarely needed for post-D&C hemorrhage)
  • Hysterectomy as last resort for uncontrolled bleeding

Post-Procedure Monitoring

After successful balloon placement:

  • Monitor vital signs every 15 minutes initially, then hourly
  • Assess for continued bleeding around the balloon
  • Plan removal at 18-24 hours if hemostasis achieved
  • Ultrasound at 6 weeks postpartum to confirm normal uterine involution 2
  • Send all tissue for histopathological examination to exclude trophoblastic disease 1

The Bakri balloon represents a fertility-preserving, minimally invasive intervention with high success rates that should be deployed early in the management algorithm for refractory hemorrhage during emergency D&C for missed miscarriage 1, 4, 2.

References

Guideline

management of gestational trophoblastic disease: green-top guideline no. 38 - june 2020.

BJOG : an international journal of obstetrics and gynaecology, 2021

Research

The safety and effectiveness of Bakri balloon in the management of postpartum hemorrhage: a systematic review.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2021

Guideline

amniotic fluid embolism: diagnosis and management.

American Journal of Obstetrics and Gynecology, 2016

Guideline

placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a.

BJOG : an international journal of obstetrics and gynaecology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.